clinical trial · NCT00157937
A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)
Organon and Co·phase4·completed·n = 31
AsthmaAllergic RhinitisMK0476; montelukast sodium/Duration of Treatment: 16 weeksComparator: theophylline ER/Duration of Treatment: 16 weeks
brief summary
Subjects have 8-week with montelukast sodium or comparator drug administration period, 2-week wash-out period and 8-week comparator drug or the drug administration period (with cross-over design) for assessment of the drug efficacy, safety and tolerability.
started
Feb 1, 2003
primary completion
Jun 1, 2005
completion
Jun 1, 2005
last updated
Aug 15, 2024
official title
A Randomized, Open Label, Cross-Over Study Comparing Effectiveness for the Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol